Steady M&A Deals to Begin 2025, Disappointing IPOs So Far
So, it was a healthy start to the year, M&A-wise, for one of the worst-performing sectors of the S&P 500® in 2024. The Health ...
Analysts Have Conflicting Sentiments on These Healthcare Companies: TransMedics Group (TMDX), Amgen (AMGN) and IQVIA Holdings (IQV)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on TransMedics Group (TMDX – Research Report), Amgen (AMGN – ...